Severe Asthma Reduced in Phase 3 Benralizumab Tests
Asthma, News
AstraZeneca recently announced that the new severe asthma medicine benralizumab met the primary endpoints in two Phase 3 registration trials. Findings of the trials called SIROCCO and CALIMA, revealed that the monoclonal antibody compound ... Read more